News > Sexuality and fertility discussions sidelined during breast cancer treatment

Sexuality and fertility discussions sidelined during breast cancer treatment

At the 2022 San Antonio Breast Cancer Symposium, LBBC leaders present needs assessment of young women that shows they often don't have needed conversations with their health care providers


“[Sexual side effects] are a natural consequence of what you’re going to experience, but you don’t know what to expect until you take the medicine and your libido goes away,” said Sara Montiel, 40, of Lexington, MA. She was treated for stage III breast cancer four years ago in Florida. “You’re going to take the medicine because your priority is to stay alive, but issues like vaginal dryness are real and addressing them in advance with your partner would help the conversation.”

The survey also found that the percentage of young women who reported discussing fertility issues with their health care providers was 49%, just slightly higher than was reported eight years earlier (46%) in a 2012 LBBC assessment.


As a community, we must continue to advocate on behalf of young women with breast cancer. We've seen some positive gains, including an increase in the number of young women accessing genetic counseling and testing, but we cannot rest until those gains are seen across all groups of women impacted by the disease.

Jean Sachs, MSS, MLSP, CEO of Living Beyond Breast Cancer


In the 2020 survey, 90% of respondents reported receiving genetic testing, but those numbers were 82% for Black participants and 35% for Hispanic respondents.

In other findings, respondents reported experiencing stress, depression, and problems with their emotions an average of 9 days in the past month, twice the average among U.S. women.


Addressing impacts on fertility and sexual health are a critical gap in the management and survivorship of women diagnosed with breast cancer. As a community, we need to do better.

Arin Ahlum Hanson, MPH, LBBC director of outreach and lead author


The poster (PD8-07) will be presented at 5 p.m. CT, Wednesday December 7, 2022, during Spotlight Poster Discussion #8. Abstracts for the Wednesday session are available at Download the poster here (PDF).

The 2020 survey consisted of an 88-item online questionnaire administered by REDCap between August and September 2020 among U.S. women diagnosed at or before age 45 with any stage of breast cancer. About 9% of new breast cancer diagnoses in the U.S. are women under age 45. Of the 717 women completing the survey, 72% were Caucasian, 14% Black, and 6% Hispanic. Of the total, 61% had been diagnosed in the past five years, and 25% of the total were diagnosed with Stage IV metastatic disease.

Both the 2012 and 2020 needs assessments were part of LBBC’s Young Women’s Initiative, a program funded through a cooperative agreement with the U.S. Centers for Disease Control. Other programs in the initiative include webinars, conference sessions, publications, and advocacy trainings tailored to young women. In addition, LBBC curates the latest breast cancer research on young women, profiles young women in its award-winning blog, and works with young women affected by breast cancer to produce videos about health topics relevant to them. For more information, visit

Contact: Katherine Pflaumer, SteegeThomson Communications

267-670-7001 (direct)